Oorja Bio, Inc.
PrivateLast Round
Series A
May 19, 2026
Total Funding Raised
$30M
Company Overview
Oorja Bio is a clinical-stage biotechnology company developing therapies for idiopathic pulmonary fibrosis (IPF) and other fibrotic and cardiopulmonary diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Clinical Trials, Drug Discovery
Business Model
B2B
Customer Profile
Revenue Share, Government Contracts
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Oorja Bio, Inc. Comps
Public and private peers based on sector, stage, and business model.
Oorja Bio, Inc. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series A | May 19, 2026 |
Oorja Bio, Inc. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Westlake Village Biopartners | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- May 19, 2026
$30M round led by Westlake Village Biopartners
- May 19, 2026
$30M round led by Westlake Village Biopartners
Oorja Bio, Inc. Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Oorja Bio, Inc.'s valuation, stock price, and market status.
